Navigation Links
Aurigene Announces Transition of Multiple Programs to Clinical Development in its Collaboration Business
Date:4/18/2013

BRIDGEWATER, New Jersey, April 18, 2013 /PRNewswire/ --

Aurigene has had a number of collaboration programs with large pharma companies over the years, and has reported successes in these programs.

     (Logo: http://photos.prnewswire.com/prnh/20130418/608115)

Elaborating on the successful collaboration programs, Aurigene's CEO CSN Murthy said "Aurigene combines its excellent execution of integrated drug discovery programs with the deep biological insights and clinical expertise of its pharma partners, and this has resulted in a very efficient model that delivers clinical candidates in timelines of 3 years or less in challenging programs."

One of Aurigene's pharma collaborations, covering 4 different programs in oncology, has seen the company delivering a clinical candidate currently in Ph 1 trials in the hands of its partner. Two other challenging programs, both potentially first-in-class molecules, are in late stages of lead optimization, with the potential to reach clinical development over the next 12-15 months. This represents a high success percentage, delivered in a highly cost-efficient and timely manner.

In another large pharma collaboration, Aurigene has been working in a niche area of inflammatory disorders, and has delivered, within 30 months of the start of the collaboration a very exciting clinical candidate for an unmet medical need. This drug candidate is in late stages of regulatory toxicology studies, and could potentially enter the clinic before the end of the current calendar year, subject to regulatory clearances. "Previous attempts to develop candidates against this target by other companies have resulted in compounds with sub-optimal properties, and could not get beyond initial clinical trials. Aurigene's candidate is the first compound against this target that has the potential to overcome the shortcomings observed in the competitor's compounds," said it
'/>"/>

SOURCE Aurigene
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
2. Young Innovations, Inc. Announces Record Sales and EPS for the Quarter Ended March 31, 2012
3. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
4. Misonix Announces New Distribution Agreement For Panama
5. University of Maryland BioPark Announces MedImmunes Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
6. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
7. Boston Scientific Announces CE Mark and European Launch of Emerge™ PTCA Dilatation Catheter
8. Soligenix Announces Further Progress with ThermoVax™ for Long-Term Vaccine ThermoStability
9. Masimo Announces New Low-Profile Infant and Neonatal Pulse Oximetry Sensors
10. Anthera Announces the Completion of Patient Dosing in Phase 2b PEARL-SC Study
11. STAAR Surgical Announces First Quarter 2012 Results Release Date and Conference Call and Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... SOUTH PLAINFIELD, N.J. , Aug. 20, 2014 PTC ... it will participate at two upcoming investor conferences: ... Four Seasons Hotel in Boston on ... Annual Biotech Conference at The Mandarin Oriental Boston on Thursday, ... will present a company update at the Bank of America ...
(Date:8/20/2014)... , Aug. 20, 2014 Reportlinker.com ... is available in its catalogue: ... Key Trends and Opportunities to 2017 ... Synopsis The report provides in depth ... Canadian personal accident and health insurance segment, ...
(Date:8/20/2014)... 20, 2014 Children aren,t the only ... to help prevent disease. The Centers for Disease ... adults, but currently, many adults are not following ... Immunization Awareness Month, and the American Lung Association ... those with lung disease, to talk with their ...
Breaking Medicine Technology:PTC Therapeutics to Participate at Upcoming Investor Conferences 2Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 2Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 3Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 4Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 5Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 6Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 7Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 8Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 9Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 10Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 11Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 12Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 13Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 14Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 15Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 16Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 17Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 18Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 19Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 20Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 21Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 22Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 23American Lung Association Urges Adults with Lung Disease to Consult their Health Care Provider to Stay Current on Vaccinations 2American Lung Association Urges Adults with Lung Disease to Consult their Health Care Provider to Stay Current on Vaccinations 3
... Jan. 23, 2012   South Florida Radiation Oncology, LLC (SFRO) ... with Mevion Medical Systems to purchase the MEVION S250 ... develop the first proton therapy treatment center in West ... targeted to begin in 2013. South ...
... (B. Braun), a leader in infusion therapy and pain management, ... approval for 2g Cefazolin for Injection USP and Dextrose ... The FDA approval makes B. Braun the first ... and other healthcare settings where it is a frequently prescribed ...
Cached Medicine Technology:South Florida Radiation Oncology to Develop Proton Therapy Center 2B. Braun Becomes the First to Deliver FDA-Approved 2g Cefazolin 2B. Braun Becomes the First to Deliver FDA-Approved 2g Cefazolin 3
(Date:8/20/2014)... -- Pigs, hearts transplanted into baboons survived for more ... previously achieved, researchers report. The work is part ... to shorten transplant waiting lists. In this study, ... abdomens. The genetic engineering and new methods of suppressing ... hearts to survive for more than a year. ...
(Date:8/20/2014)... Dennis Thompson HealthDay Reporter ... help older women avoid a condition that causes a life-threatening ... women had a 10 percent lower risk of developing atrial ... in the Aug. 20 issue of the Journal of ... protection against the heart rhythm disorder even if they were ...
(Date:8/20/2014)... The Board of Directors of top ... is pleased to announce the expansion of its ... and the surrounding region. In support of this ... AIA has relocated to the firm’s office in Shanghai, ... and design and to better support regional clients. ...
(Date:8/20/2014)... to treating kidney failure by removing waste products from ... who suddenly developed the condition, in an analysis led ... Medicine. , Their findings, published online in the journal ... method that is standardly used for people with sudden ... the patient. , "Our findings question the accepted notion ...
(Date:8/20/2014)... 2014 As concerns regarding the health ... ( http://www.injurybeacon.com/power-morcellator/ ) in gynecological surgery continue to ... from New York are urging the U.S. Food & ... devices. In a letter dated August 19th, Sens. Kirsten ... agency to seriously consider the testimony given during the ...
Breaking Medicine News(10 mins):Health News:Pigs' Hearts Beat for a Year in Baboons' Abdomens 2Health News:Exercise May Guard Against Irregular Heartbeat in Older Women 2Health News:Exercise May Guard Against Irregular Heartbeat in Older Women 3Health News:Perkins Eastman Expands Presence in China 2Health News:Perkins Eastman Expands Presence in China 3Health News:Pitt analysis questions use of acute hemodialysis treatment 2Health News:Power Morcellator News: Bernstein Liebhard LLP Notes Senators’ Letter Seeking FDA Morcellator Recall 2Health News:Power Morcellator News: Bernstein Liebhard LLP Notes Senators’ Letter Seeking FDA Morcellator Recall 3Health News:Power Morcellator News: Bernstein Liebhard LLP Notes Senators’ Letter Seeking FDA Morcellator Recall 4
... Giving breastfeeding infants of HIV-infected mothers a daily dose ... the risk of HIV transmission to the infants at ... daily for six weeks, according to preliminary clinical trial ... a 75 percent reduction in HIV transmission risk through ...
... , WEDNESDAY, March 2 (HealthDay News) -- Moms-to-be ... oxycodone (Oxycontin) may increase the risk of birth ... report. Taking these types of analgesics just prior to ... to a modest risk of congenital heart defects in an ...
... of Chemistry at Stevens Institute of Technology, recently ... of Michigan. Named in honor of pioneer pharmaceutical ... established to recognize outstanding lifetime achievements in medicinal ... lecture, "Drug Discovery Lessons Learned," was delivered ...
... , WEDNESDAY, March 2 (HealthDay News) -- ... have uncontrolled seizures, drug-related side effects, and a lower ... money, finds a new study. Poor patients also ... appointments with a general practitioner, according to lead author ...
... awarded Arizona State University (ASU) a $1 million grant ... Ph.D., at the Biodesign Institute. The team is working ... a "Cell-CT" scanner, that will perform functional computed tomographic ... will allow researchers to observe and assess the cellular ...
... Amanda Gardner HealthDay Reporter , TUESDAY, March ... or young adult raises your risk of having psychotic ... "This cements much more firmly the reality that ... with the other genetic, environmental and socioeconomic risk factors, ...
Cached Medicine News:Health News:6-month drug regimen cuts HIV risk for breastfeeding infants, NIH study finds 2Health News:6-month drug regimen cuts HIV risk for breastfeeding infants, NIH study finds 3Health News:CDC Links Prescription Painkillers in Pregnancy to Birth Defects 2Health News:Stevens' Dr. A. K. Ganguly receives Topliss Award Lecture from University of Michigan 2Health News:$1 million from W.M. Keck Foundation spurs development of new generation 3-D 'Cell-CT' imaging 2Health News:$1 million from W.M. Keck Foundation spurs development of new generation 3-D 'Cell-CT' imaging 3Health News:Pot Use in Youth Ups Risk of Psychotic Symptoms in Later Life 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: